Presentation TCT 2017 TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement Presenter: Maria Del Trigo, MD October 31, 2017 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2017 Aortic Valve Up Next Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Tarun Chakravarty, MD October 31, 2017 More slides + Presentation TCT 2017 TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation Presenter: Armando Tellez, MD October 31, 2017 Presentation TCT 2017 TCT 65: Reclassification of Revascularization Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Report from the iFR-SWEDEHEART Study Presenter: Matthias Götberg, MD October 31, 2017 We Recommend
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation Presenter: Armando Tellez, MD October 31, 2017
Presentation TCT 2017 TCT 65: Reclassification of Revascularization Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Report from the iFR-SWEDEHEART Study Presenter: Matthias Götberg, MD October 31, 2017